{"metadata": {"source": "pubchem", "title": "Morphine | C17H19NO3 | CID 5288826 - PubChem", "description": "Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5288826", "drug": "Morphine", "cid": 5288826, "char_count": 201355, "word_count": 27013, "doc_id": "doc_53", "num_chunks": 298, "chunk_id": "53::chunk_142", "document_index": 53, "latency_s": 1.4332315999927232, "prompt_toks": 53771, "completion_toks": 97, "relevance_score": 0.0018895386}, "content": "Drug: Morphine | cid: 5288826\nSource: pubchem | Source description: Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    A prospective cohort study of postcesarean pain control compared (1) morphine PCA and scheduled ibuprofen for the first 12 hours followed by continued scheduled ibuprofen with hydrocodone-acetaminophen as needed to a multimodal pain management regimen consisting of (2) acetaminophen 1000 mg orally every 8 hours, ketorolac 30 mg IV once initially, then 15 mg IV every 8 hours for 24 hours, then ibuprofen 600 mg orally every 8 hours for the remainder of the postoperative course with opioids given only as needed. Of women who planned to exclusively breastfeed on admission, fewer women used formula prior to discharge in the multimodal group compared to the traditional group (9% vs. 12%).\n\nA study compared 2 mg of epidermal morphine to saline given within 1 hour after vaginal delivery. No differences were found between the two groups in the rates of any breastfeeding or exclusive breastfeeding at 1 or 6 weeks postpartum.\n\n◈ What is morphine?\n\n\n                    Context: \n                    This chunk summarizes clinical studies related to morphine use in postpartum and post-vaginal delivery pain management, highlighting its effects on breastfeeding rates and postpartum care strategies. It provides specific comparisons of multimodal pain control regimens and their impact on breastfeeding versus formula use, and discusses efficacy and safety data on epidural morphine administration. As part of the full webpage, it emphasizes morphine’s role in obstetric pain treatment and its relevance to breastfeeding safety and clinical outcomes.\n                "}
{"metadata": {"source": "psychonaut", "title": "Morphine - PsychonautWiki", "description": "Morphine is a naturally-occurring opioid substance of the morphinan class. It is one of the natural plant alkaloids found in opium, along side codeine which is extracted from Papaver somniferum (also known as the poppy plant).[6] Additionally, it is considered to be the prototype opiate (i.e. the standard to which others are compared) and the basis of derivatives such as codeine, diacetylmorphine (heroin), and hydrocodone.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Morphine", "drug": "Morphine", "cid": 5288826, "char_count": 29485, "word_count": 4133, "doc_id": "doc_90", "num_chunks": 38, "chunk_id": "90::chunk_2", "document_index": 90, "latency_s": 1.3153301999991527, "prompt_toks": 8122, "completion_toks": 70, "relevance_score": 0.00023413582}, "content": "Drug: Morphine | cid: 5288826\nSource: psychonaut | Source description: Morphine is a naturally-occurring opioid substance of the morphinan class. It is one of the natural plant alkaloids found in opium, along side codeine which is extracted from Papaver somniferum (also known as the poppy plant).[6] Additionally, it is considered to be the prototype opiate (i.e. the standard to which others are compared) and the basis of derivatives such as codeine, diacetylmorphine (heroin), and hydrocodone.\n\n                    Text: \n                    3.33 - 5 mg Common 5 - 7.5 mg Strong 7.5 - 10 mg Heavy 10 mg + [2] [3] [4] [5] Duration Total 4 - 5 hours Onset 0 - 30 seconds Come up 2 - 5 minutes Peak 1.5 - 2.5 hours Offset 60 - 90 minutes After effects 12h DISCLAIMER : PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. Interactions MAOIs Nitrous PCP Stimulants Alcohol Benzodiazepines DXM GHB GBL Ketamine MXE Tramadol Grapefruit\n\n\n                    Context: \n                    This excerpt provides specific oral dosage guidelines, onset, duration, and interaction warnings for morphine, essential for understanding safe administration practices. It is part of the comprehensive section on drug effects, dosage, and safety within the full document, supporting harm reduction and responsible use information. This data aids users in identifying appropriate doses and potential drug interactions to minimize risks.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 46, "doc_id": "doc_275", "num_chunks": 9, "chunk_id": "275::chunk_1", "document_index": 275, "latency_s": 0.8718463999975938, "prompt_toks": 1835, "completion_toks": 72, "relevance_score": 0.00023231418}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Infobox: Morphine | Chemical Nomenclature | Common names | Morphine, MS-Contin, Oramorph, Zomorph, Sevredol, Duramorph | Substitutive name | Morphine | Systematic name | (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol | Class Membership | Psychoactive class | Opioid | Chemical class | Morphinan | Routes of Administration | WARNING: | Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. | See responsible use section | . | ⇣ | Oral | Dosage | Bioavailability | 35% - 40% | Threshold | < 10 mg | Light | 10 - 15 mg | Common | 15 - 20 mg | Strong | 20 - 30 mg | Heavy | 30 mg + | Duration | Total | 4 - 6 hours | Onset | 10 - 30 minutes | Come up | 20 - 40 minutes | Peak | 2 - 3 hours | Offset | 1 - 2 hours | After effects | 12h | ⇣ | Intravenous | Dosage | Bioavailability | 100% | Threshold | < 3.33 mg | Light | 3.33 - 5 mg | Common | 5 - 7.5 mg | Strong | 7.5 - 10 mg | Heavy | 10 mg + | [2] | [3] | [4]\n\n\n                    Context: \n                    This chunk provides detailed pharmacological information about morphine, including its common names, chemical nomenclature, routes of administration with dosage guidelines, bioavailability, onset and duration of effects, and references to its intravenous use. It is essential for understanding morphine's medical and recreational use parameters within the comprehensive overview of its effects, toxicity, and legal status.\n                "}
